Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00790816
Title Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | ESP | CAN

Facility Status City State Zip Country Details
Novartis Investigative Site Scottsdale Arizona 85259 United States Details
Novartis Investigative Site Tucson Arizona 85724 United States Details
Novartis Investigative Site Santa Monica California 90404 United States Details
Novartis Investigative Site Washington District of Columbia 20007 United States Details
Novartis Investigative Site Fort Myers Florida 33916 United States Details
Novartis Investigative Site Atlanta Georgia 30341 United States Details
Novartis Investigative Site Detroit Michigan 48202 United States Details
Novartis Investigative Site Lebanon New Hampshire 03756 United States Details
Novartis Investigative Site Buffalo New York 14263 United States Details
Novartis Investigative Site Durham North Carolina 27710 United States Details
Novartis Investigative Site Cleveland Ohio 44106 United States Details
Novartis Investigative Site Greenville South Carolina 29605 United States Details
Novartis Investigative Site Memphis Tennessee 38120 United States Details
Novartis Investigative Site Nashville Tennessee 37203 United States Details
Novartis Investigative Site Salt Lake City Utah 84112 United States Details
Novartis Investigative Site Edmonton Alberta T6G 1Z2 Canada Details
Novartis Investigative Site Montreal Quebec H2W 1T8 Canada Details
Novartis Investigative Site Seoul 110-744 Korea, Republic of Details
Novartis Investigative Site Seoul 120-752 Korea, Republic of Details
Novartis Investigative Site Seoul 135-710 Korea, Republic of Details
Novartis Investigative Site Songpa-gu, Seoul 138-736 Korea, Republic of Details
Novartis Investigative Site Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Hospitalet de Llobregat (Barcelona) 08907 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field